Hypersensitivity to Trastuzumab, murine proteins or to any other component of Zuhera.
Severe dyspnoea at rest due to complications of advanced malignancy.
Requiring supplementary oxygen therapy.
See Composition under Description for list of components of Zuhera.
Data in the following section (see Precautions) has been taken from publicly available data on Trastuzumab.